Phenotypic Polypharmacology Drug Discovery for CNS Applications

Keyphrases

• Drug Discovery 100%
• Central Nervous System 100%
• Agnostic 100%
• Drug Polypharmacology 100%
• System Application 100%
• Phenotypic Profiling 40%
• Central Nervous System Drugs 40%
• Mechanism of Action 20%
• Structure-activity Relationship 20%
• High-throughput 20%
• Good Strategies 20%
• Placebo 20%
• Artificial Intelligence 20%
• Holistically 20%
• Machine Learning 20%
• Neuropsychiatric Disorders 20%
• Antipsychotics 20%
• Structural Modification 20%
• Tolerability 20%
• First-in-class 20%
• High Content 20%
• Discovery-based 20%
• Neurotransmitter Systems 20%
• Intelligence Learning 20%
• Multi-target 20%
• Dopamine Receptor 20%
• Prosecute 20%
• Lead Optimization 20%
• Therapeutic Window 20%
• Phenotypic Drug Discovery 20%
• Pharmacological Targets 20%
• Polypharmacology 20%
• Novel Central Nervous System Drugs 20%
• Phenotypic Profile 20%
• 2,1-benzisoxazoles 20%
• SmartCube 20%
• Drug pipeline 20%
• Phase III Clinical Trial 20%
• Ulotaront 20%
• History of Psychopharmacology 20%
• Tryptamine 20%
• Psychiatric Medication 20%
• New Leads 20%
• Behavior Phenotype 20%
• Privileged Scaffold 20%
• Central Nervous System Effects 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Drug Discovery 100%
• Central Nervous System Drug 28%
• Structure Activity Relationship 14%
• Clinical Trial 14%
• Placebo 14%
• Neurotransmitter 14%
• Antipsychotic 14%
• Dopamine Receptor 14%
• Tolerability 14%
• Central Nervous System Agent 14%
• Tryptamine 14%
• Therapeutic Window 14%
• Psychopharmacology 14%